The Food and Drug Administration said Wednesday it will grant emergency-use authorization for a booster shot of Pfizer's two-dose coronavirus vaccine for people 65 and older, those at high risk of severe disease and people with high-risk jobs.
The post FDA Authorizes Pfizer COVID Booster for Senior, High-Risk Groups appeared first on The Washington Informer.
